Zurück zur Übersicht
| Journal of neural transmission (Vienna, Austria : 1996). 2017 Aug 2. doi: 10.1007/s00702-017-1773-0. pii: 10.1007/s00702-017-1773-0 |
| Genome-wide significant, replicated and functional risk variants for Alzheimer's disease. |
| Guo X1, Qiu W2, Garcia-Milian R3, Lin X4, Zhang Y5, Cao Y6, Tan Y7, Wang Z8, Shi J9, Wang J10, Liu D11, Song L12, Xu Y13, Wang X14, Liu N15, Sun T16, Zheng J17, Luo J18, Zhang H19, Xu J20, Kang L21, Ma C22, Wang K23, Luo X24 |
 Author information
|
|
Abstract Genome-wide association studies (GWASs) have reported numerous associations between risk variants and Alzheimer's disease (AD). However, these associations do not necessarily indicate a causal relationship. If the risk variants can be demonstrated to be biologically functional, the possibility of a causal relationship would be increased. In this article, we reviewed all of the published GWASs to extract the genome-wide significant (p < 5×10(-8)) and replicated associations between risk variants and AD or AD-biomarkers. The regulatory effects of these risk variants on the expression of a novel class of non-coding RNAs (piRNAs) and protein-coding RNAs (mRNAs), the alteration of proteins caused by these variants, the associations between AD and these variants in our own sample, the expression of piRNAs, mRNAs and proteins in human brains targeted by these variants, the expression correlations between the risk genes and APOE, the pathways and networks that the risk genes belonged to, and the possible long non-coding RNAs (LncRNAs) that might regulate the risk genes were analyzed, to investigate the potential biological functions of the risk variants and explore the potential mechanisms underlying the SNP-AD associations. We found replicated and significant associations for AD or AD-biomarkers, surprisingly, only at 17 SNPs located in 11 genes/snRNAs/LncRNAs in eight genomic regions. Most of these 17 SNPs enriched some AD-related pathways or networks, and were potentially functional in regulating piRNAs and mRNAs; some SNPs were associated with AD in our sample, and some SNPs altered protein structures. Most of the protein-coding genes regulated by the risk SNPs were expressed in human brain and correlated with APOE expression. We conclude that these variants were most robust risk markers for AD, and their contributions to AD risk was likely to be causal. As expected, APOE and the lipoprotein metabolism pathway possess the highest weight among these contributions. |
|
KEYWORDS: APOE, Alzheimer’s disease, GWAS, Gene expression, Genome-wide significant, Replicated, Risk variant |
|
Publikations ID: 28770390 Quelle: öffnen |
Author information
Schnellinfo
-- Cancer Care
-- Kliniken und Partner
-- CCC Cancer School
-- Young CCC
-- CCC Tumorboards
-- CCC Forschungscluster
-- CCC Units
-- CCC Platforms
-- SOPs / Leitlinien
-- Kontakt
Featured
